Mesh : Anti-Anxiety Agents / adverse effects metabolism therapeutic use Benzodiazepines / adverse effects therapeutic use Flurazepam / therapeutic use Half-Life Humans Midazolam Sleep / drug effects Sleep Initiation and Maintenance Disorders / drug therapy etiology Triazolam / adverse effects therapeutic use

来  源:   DOI:10.1126/science.6131538   PDF(Sci-hub)

Abstract:
Early morning insomnia, a significant increase in wakefulness during the final hours of drug nights, occurred after 1 or 2 weeks of nightly administration of benzodiazepine hypnotics with short elimination half-lives, when tolerance had begun to develop. Early morning insomnia may be a variant of rebound insomnia and therefore specific to benzodiazepines, or it may occur with any rapidly eliminated sedative-hypnotic agent.
摘要:
清晨失眠,在药物之夜的最后几个小时,清醒度显著增加,发生在每晚服用苯二氮卓催眠药1或2周后,消除半衰期短,当耐受性开始发展时。清晨失眠可能是反弹失眠的一种变体,因此对苯二氮卓类药物具有特异性,或者它可能发生与任何迅速消除镇静催眠剂。
公众号